Literature DB >> 25123844

Neurodevelopmental delays and macrocephaly in 17p13.1 microduplication syndrome.

Kathryn Anne Mooneyham1, Kenton R Holden, Sara Cathey, Alka Dwivedi, Barbara R Dupont, Michael J Lyons.   

Abstract

Microduplication of chromosome 17p13.1 is a rarely reported chromosome abnormality associated with neurodevelopmental delays. We describe two unrelated patients with overlapping microduplications of chromosome 17p13.1. The first patient is a 2-year-old male who presented with neurodevelopmental delays and macrocephaly. He was found to have a de novo 788 kb copy gain of 17p13.2p13.1 and a de novo 134 kb copy gain of 17p13.1. These duplications include multiple candidate genes, including EFNB3, NLGN2, DLG4, GABARAP, and DULLARD, which may be responsible for neurodevelopmental delays in affected individuals. The second patient is a 29-year-old female with mild intellectual disability and relative macrocephaly. She was found to have a 62.5 kb copy gain of chromosome 17p13.1 that includes the DLG4, GABARAP, and DULLARD genes. The DLG4, GABARAP, and DULLARD genes included in the microduplications of both our patients appear to be candidate genes for neurodevelopmental delays and macrocephaly in individuals with 17p13.1 microduplication syndrome.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  17p13.1; duplication; macrocephaly; neurodevelopmental delays

Mesh:

Year:  2014        PMID: 25123844     DOI: 10.1002/ajmg.a.36708

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Endocrinological Abnormalities Are a Main Feature of 17p13.1 Microduplication Syndrome: A New Case and Literature Review.

Authors:  Ilenia Maini; Ivan Ivanovski; Alessandro Iodice; Simonetta Rosato; Marzia Pollazzon; Manuela Mussini; Elga F Belligni; Charles Coutton; Maria Marinelli; Veronica Barbieri; Manuela Napoli; Rosario Pascarella; Chiara Sartori; Francesca Madia; Carlo Fusco; Fabrizia Franchi; Maria E Street; Livia Garavelli
Journal:  Mol Syndromol       Date:  2016-10-14

2.  Absence of RNA-binding protein FXR2P prevents prolonged phase of kainate-induced seizures.

Authors:  Adrian C Lo; Nicholas Rajan; Denise Gastaldo; Ludovic Telley; Muna L Hilal; Andrea Buzzi; Michele Simonato; Tilmann Achsel; Claudia Bagni
Journal:  EMBO Rep       Date:  2021-03-28       Impact factor: 8.807

3.  Investigation of Chromosomal Structural Abnormalities in Patients With Undiagnosed Neurodevelopmental Disorders.

Authors:  Ye Cao; Ho Ming Luk; Yanyan Zhang; Matthew Hoi Kin Chau; Shuwen Xue; Shirley S W Cheng; Albert Martin Li; Josephine S C Chong; Tak Yeung Leung; Zirui Dong; Kwong Wai Choy; Ivan Fai Man Lo
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

4.  Physical Interactions and Functional Relationships of Neuroligin 2 and Midbrain Serotonin Transporters.

Authors:  Ran Ye; Meagan A Quinlan; Hideki Iwamoto; Hsiao-Huei Wu; Noah H Green; Christopher S Jetter; Douglas G McMahon; Jeremy Veestra-VanderWeele; Pat Levitt; Randy D Blakely
Journal:  Front Synaptic Neurosci       Date:  2016-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.